Assessment of Acceptability of Pre-exposure Prophylaxis for HIV Prevention Among Men Who Sex with Men and Transgender Community in Pakistan

被引:0
作者
Ali, Usman [1 ]
Pasha, Safdar Kamal [2 ]
Patel, Rupa [3 ]
Schmidt, Heather-Marie [4 ,5 ]
Altaf, Arshad [6 ]
机构
[1] King Edward Med Univ, Mayo Hosp, Dept Psychiat & Behav Sci, Lahore, Pakistan
[2] WHO, Dept HIV Viral Hepatitis & Sexually Transmitted In, Islamabad, Pakistan
[3] Washington Univ, Dept Internal Med, St Louis, MO USA
[4] WHO, Dept Testing Prevent, Geneva, Switzerland
[5] WHO, UNAIDS Asia Pacific Reg, Populat Unit, Geneva, Switzerland
[6] WHO, Eastern Mediterranean, Cairo, Egypt
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2023年 / 33卷 / 09期
关键词
Gay; Men who have sex with men; HIV; Pre-exposure prophylaxis Pakistan; Transwomen; Chemsex; People living with HIV; MSM; VIETNAM;
D O I
10.29271/jcpsp.2023.09.983
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the level of acceptability of oral pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) and transwomen (TW) in Pakistan.Study design: Cross-sectional study. Place and Duration of the Study: Online study portal from September to November 2021.Methodology: The study participants were recruited through snowball sampling. Consenting individuals who were >13 years and were identified as MSM or TW were included in the study. Data were analysed using SPSS version 25. Frequencies, percentages and correlation coefficients were computed.Results: A total of 347 participants were recruited. The mean age of all participants was 29.8 +/- 6.7 years. Fifty-eight (19.7%) of the participants had chemsex with amphetamine-type stimulants (ATS) at least once in preceding six months of the study, and 58 (19.7%) had a sexually transmitted infection (STI) in preceding six months whereas 10 (3.4%) participants had used drugs via injection. Two hundred and thirty-eight (72%) of the participants were aware of PrEP, 30 (11.7%) had used PrEP in the past, and 3.88% were currently using PrEP. The willingness to use PrEP, free of cost, was shown by 300 participants (86.45%) and by 180 (54.5%), if available at a low cost.Conclusion: There was a high prevalence of risk factors posing them at considerable risk of human immunodeficiency virus (HIV). The majority was aware of PrEP for HIV prevention. The willingness to use PrEP was high when PrEP was offered free of cost but dropped down when participants were asked to pay for PrEP. Based on this finding, PrEP should be available free of cost at the community preferred outlets.
引用
收藏
页码:983 / 989
页数:7
相关论文
共 25 条
[1]  
Anand T, 2019, HEPHIV2019 C BUCH
[2]  
[Anonymous], Pakistan AIDS Strategy IV 2021-2025
[3]  
[Anonymous], Asia and the Pacific data 2020
[4]  
[Anonymous], 2022, Guidelines on Long-Acting Injectable Cabotegravir for HIV Prevention
[5]  
[Anonymous], Country progress report-Pakistan Global AIDS Monitoring 2020
[6]  
[Anonymous], 2017, Pakistan Report
[7]  
[Anonymous], PREEXPOSURE PROPHYLA
[8]  
[Anonymous], 2021, Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach M/OL
[9]  
[Anonymous], FDA approves first injectable treatment for HIV pre-exposure prevention
[10]   My PrEP Locator: PrEP directory in Malaysia [J].
Chong, M. L. ;
Galka, J. ;
Noh, R. Mohd ;
Azwa, R. I. S. Raja .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 :204-205